U. Oflazoglu Et Al. , "A prospective randomized controlled trial of metoclopramide combined with triple antiemetic therapy to prevent anthracycline-based chemotherapy-induced nausea and vomiting in patients with breast cancer," 43rd ESMO Congress (ESMO) , vol.29, Munich, Germany, pp.610, 2018
Oflazoglu, U. Et Al. 2018. A prospective randomized controlled trial of metoclopramide combined with triple antiemetic therapy to prevent anthracycline-based chemotherapy-induced nausea and vomiting in patients with breast cancer. 43rd ESMO Congress (ESMO) , (Munich, Germany), 610.
Oflazoglu, U., Varol, U., Alacacioglu, A., Salman, T., Kucukzeybek, Y., Taskaynatan, H., ... Yildiz, Y.(2018). A prospective randomized controlled trial of metoclopramide combined with triple antiemetic therapy to prevent anthracycline-based chemotherapy-induced nausea and vomiting in patients with breast cancer . 43rd ESMO Congress (ESMO) (pp.610). Munich, Germany
Oflazoglu, U. Et Al. "A prospective randomized controlled trial of metoclopramide combined with triple antiemetic therapy to prevent anthracycline-based chemotherapy-induced nausea and vomiting in patients with breast cancer," 43rd ESMO Congress (ESMO), Munich, Germany, 2018
Oflazoglu, U. Et Al. "A prospective randomized controlled trial of metoclopramide combined with triple antiemetic therapy to prevent anthracycline-based chemotherapy-induced nausea and vomiting in patients with breast cancer." 43rd ESMO Congress (ESMO) , Munich, Germany, pp.610, 2018
Oflazoglu, U. Et Al. (2018) . "A prospective randomized controlled trial of metoclopramide combined with triple antiemetic therapy to prevent anthracycline-based chemotherapy-induced nausea and vomiting in patients with breast cancer." 43rd ESMO Congress (ESMO) , Munich, Germany, p.610.
@conferencepaper{conferencepaper, author={U. Oflazoglu Et Al. }, title={A prospective randomized controlled trial of metoclopramide combined with triple antiemetic therapy to prevent anthracycline-based chemotherapy-induced nausea and vomiting in patients with breast cancer}, congress name={43rd ESMO Congress (ESMO)}, city={Munich}, country={Germany}, year={2018}, pages={610} }